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Abstract
Background: Although extrapulmonary tuberculosis (EPTB) is less frequent than Pulmonary Tuberculosis (PTB) and
is a secondary target for national TB control programs, its significance has increased worldwide during the HIV
epidemic. The objective of this study was to examine the epidemiology of EPTB in Brazil between 2007 and 2011.
Methods: Cross-sectional study involving all cases of TB reported to the Brazilian Notifiable Diseases Surveillance
System (Sistema de Informações de Agravo de Notificação - SINAN) in Brazil between 2007 and 2011.
Sociodemographic and clinical characteristics of patients with exclusively PTB and exclusively EPTB were compared.
Following analysis with Pearson’s chi-square test, variables with p < 0.05 were included in a hierarchical regression
model. Variables with p < 0.05 in the corresponding level were kept in the model.
Results: A total of 427,548 cases of TB were included. Of these, 356,342 cases (83.35%; 95% confidence interval (CI)
83.23% - 83.45%) were PTB, 57,217 (13.37%; 95% CI 13.28% - 13.48%) were EPTB, 13,989 (3.27%; 95% CI 3.21% - 3.32%)
were concurrent pulmonary and extrapulmonary TB. Patients with EPTB were mainly white (16.7%), and most (29.1%)
patients had five to eight years of education. Among comorbidities, HIV infection was prominent (OR 2.15; 95% CI
2.09 – 2.21), although the proportion of cases awaiting test results or untested was high (39%). Ethanol use
(OR 0.45; 95% CI 0.43 – 0.46), diabetes mellitus (OR 0.54; 95% CI 0.51 – 0.57) and mental illness (OR 0.88; 95% CI
0.82 – 0.95) were associated with PTB.
Conclusions: Thirteen percent of patients diagnosed with TB in Brazil have only EPTB. More effective diagnostic
strategies and control measures are needed to reduce the number of cases of extrapulmonary TB in Brazil.
Background
Although data are limited, extrapulmonary disease is a
common presentation of tuberculosis (TB) in Brazil. In
2011, 14% of all cases of TB reported to the World
Health Organization (WHO) were extra-pulmonary TB
(EPTB) [1].
A national literature search demonstrated that the epi-
demiology of EPTB is infrequently mentioned. EPTB is
rarely included in publications on the epidemiological
profile of TB [2,3]. Two studies at the national level
mention EPTB only when discussing TB in persons co-
infected with human immunodeficiency virus (HIV)
[4,5]. Studies have addressed EPTB at the level of states
[6], municipalities [4,7], and healthcare services [5,8] in
Brazil, but none have addressed it at the national level.
This situation is illustrated by the omission of EPTB
from the latest epidemiological report on TB by the
Brazilian Health Ministry published in 2012 [9].
The rate of EPTB in Brazil increased from 6.8 per
100,000 people in 1981 to 7.0 per 100,000 people in 1991.
A study conducted in the municipality of Campinas, São
Paulo between 2001 and 2009 found a 23.7% reduction in
the number of cases of pulmonary TB (PTB) but only a
5.9% reduction in the number of cases of EPTB [4].
One of the main factors affecting the rate of EPTB in
Brazil is the HIV/AIDS epidemic because the development
of EPTB is favored by HIV infection and other conditions
that suppress immune function [10].
Due to the impact of the HIV epidemic on EPTB, the
scarcity of national studies of EPTB, and the relevance
of EPTB to the epidemiology of TB and TB control in
Brazil, the present study was done to examine the epi-
demiology of EPTB in Brazil during the five year period
from 2007 to 2011.
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Methods
Information systems are essential tools for the assessment
and planning of health actions. Cases of TB are recorded
by the Brazilian Notifiable Diseases Surveillance System
[Sistema de Informação de Agravos de Notificação
(SINAN)] based on data abstracted from forms used in
the investigation and follow-up of cases. SINAN is the
main survey system for collection and analysis of national
data on TB in Brazil [11,12].
A cross-sectional study was performed including all
cases of TB in Brazil reported to SINAN from January 1,
2007 to December 31, 2011. Lack of data in the variable
“clinical form of TB” on SINAN was the only reason for
exclusion from the study.
Information about the clinical form of TB is a required
field on SINAN survey system. This information is entered
by a healthcare provider at the time of notification of a
case of TB when the diagnosis of TB has been confirmed.
Although all Brazilian municipalities transmit data to
SINAN, only 70% enter their data electronically. Database
update at higher hierarchical levels is routinely conducted
through vertical data transfers from the municipality to
the state and then onwards to the Federal level [13].
Because TB diagnosis and treatment is free of charge
in Brazil and because patients must be notified in
SINAN before anti-TB treatment is started, reporting
of TB cases to SINAN and the national TB program is
reasonably complete in Brazil.
Clinical forms of TB were classified using WHO defini-
tions [14]. PTB was defined as TB affecting the lung par-
enchyma. EPTB was defined as TB affecting organs and
tissues outside of the lungs (e.g. skin, pleura, bones and
joints, meninges, etc.). Miliary TB was classified as extra-
pulmonary TB. Information on sites of extrapulmonary
disease (pleural, lymphatic, genitourinary, bone, eye, skin,
laryngeal, miliary, meningitis and others) is routinely cap-
tured in the SINAN data base [15].
First, a descriptive analysis of the absolute and relative
frequencies of patients presenting with pulmonary or
extrapulmonary TB, both pulmonary and extrapulmonary
TB, and disease at various extrapulmonary sites (pleural,
lymphatic, genitourinary, bone, eye, skin, miliary and
others) was done. Then, characteristics of cases of exclu-
sively EPTB and exclusively PTB were compared. Cases
of PTB + EPTB were excluded from this stage because
these forms of TB affect pulmonary and extrapulmonary
sites simultaneously, and the cases could not be allo-
cated to either group leading to possible classification
bias. Excluding such cases is similar to methods used in
a recent national study of extrapulmonary TB in the
USA [16].
Pearson’s chi-square test was used to compare the
rates of PTB and EPTB. Variables with a P value < 0.05
were included in a hierarchical logistic regression model.
Study variables were assessed and allocated into five
levels: Level 1 (sociodemographic) variables included
gender (female or male), age (0 to 14 years, 15 to 24
years, 25 to 34 years, 35 to 44 years, 45 to 54 years, 55
to 64 years, more than 65 years), ethnicity (white, black,
brown, Asian or Indian), and educational level (illiterate,
1 to 4 years of education, 5 to 8 years, 9 to 12 years,
greater than 12 years, non-applicable); Level 2 (environ-
mental) variables included residence (urban, rural, or
peri-urban), and institutionalization [yes (prison, nursing
home, orphanage, hospital, psychiatric institution, or
others) or no]. Level 3 (previous comorbidities) variables
included HIV/AIDS (negative or positive), alcoholism
(yes or no), diabetes (yes or no), mental illness (yes or no),
and other diseases (yes or no). Level 4 (clinical features)
variables included admission type (new case, relapse,
readmission following dropout, unknown, or transfer),
tuberculin skin test (TST) [positive (>5 mm) or nega-
tive (0 to 4 mm)], sputum smear test for acid-fast ba-
cilli (AFB) (negative or positive), culture (positive or
negative), histopathology [positive (positive AFB and
suggestive of TB) or negative TB. Level 5 (treatment
outcome of TB) variables included anti-TB treatment
administered under Directly Observed Therapy (DOT)
(yes or no) and outcome status [cure, dropout, death
by TB, death due to other causes, transfer, or multi-
drug resistant TB (MDR-TB)].
Tuberculosis is a disease with a complex causal chain.
Constructing a hierarchical model may be a better way to
capture the interrelationships between its determinants. In
this model, variables are included from distal to proximal
ones, according to different levels of a causal network aris-
ing from a robust theoretical base [17,18]. Associations
resulting from the hierarchical regression model are
adjusted for the variables in the same level and those in
previous levels, taking into account both confounders and
mediators [17,18].
The present model was based on the conceptual frame-
work for social determinants of TB formulated by Maciel
[19]. Independent variables were hierarchized into five
levels: socio-demographic (Level 1), environmental
(Level 2), previous comorbidities (Level 3), clinical fea-
tures of TB (Level 4), and outcome of anti-TB treatment
(Level 5), as outlined above.
Distinct models were used in building each level and the
variables that exhibited an association with the clinical
form of TB (p ≤ 0.05) at each level were included in the
subsequent level, resulting in the following models: level
1 – sociodemographic characteristics; level 2 – variables
included from level 1 + environmental characteristics;
level 3 – variables included from level 2 + comorbidities;
level 4 – variables included from level 3 + clinical char-
acteristics of TB; and level 5 – variables included from
level 4 + outcome variables.
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Microsoft Excel 2010 software was used to construct
the databases and generate the graphs. Statistical analysis
was performed with Stata version 11.0, and included cal-
culation of odds ratios (OR) with 95% confidence intervals
(95% CI).
The study was approved by the research ethics com-
mittee of the Center of Health Science of the Federal
University of Espírito Santo (UFES) - Record Number
121/06. The institutional review board of UFES granted
permission for use of information from the SINAN data-
base for the purposes of the study and waived the need
for written informed consent from participants as the
study involved only secondary data and the confidentiality
of the patients’ identities was protected.
Results
Study population
Between 2007 and 2011, 428,039 cases of TB were re-
ported to SINAN. Of these, 491 (0.11%) were excluded
because the clinical form of TB was not entered into
SINAN, resulting in a final sample of 427,548 cases. The
sample included 356,342 cases of PTB (83.35%; 95% CI
83.23% - 83.45%), 57,217 cases of EPTB (13.37%; 95% CI
13.28% - 13.48%), 13,989 cases of PTB + EPTB (3.27%;
95% CI 3.21% - 3.32%). The total number of cases of TB
with some type of extrapulmonary disease (all forms ex-
cept PTB) was 71,207. In 70,131 of such cases, the clinic-
ally affected sites were recorded in SINAN. Their relative
proportions are depicted in Figure 1. Only the first site of
disease reported is depicted in the figure. In 4,307 (6%)
cases of EPTB or PTB + EPTB, a second site was also
involved. Among these secondary’s sites of TB, 27.8%
involved lymph nodes, 18.8% pleural, 10.5% miliary,
8.4% laryngeal, 5.4% meningeal, 4.4% bone, 3.3% skin,
2.6% genitourinary, 1.1% ocular and 17.7% others.
The following characteristics of patients with EPTB
were prominent in the descriptive analysis: male gender
(60.7%), age of 0 to 15 years old (24.6%), white race
(16.7%), and history of five to eight years of education
(29.1%). The proportion of cases without HIV result was
39.2%; furthermore, 50.2% of the patients were not
treated under DOT and 22.4% had no information about
this variable, 9.4% of the cases were transferred out, and
71.5% were cured (data not shown). Other features of
the cases of EPTB compared to PTB are described in
Tables 1 and 2.
Comparative analysis: EPTB versus PTB
Although both PTB and EPTB were more prevalent in
males, the proportion of females with EPTB was higher
(p < 0.001). A significant difference was also observed in
the age distribution between PTB and EPTB cases. Pa-
tients aged less than fourteen years old had EPTB more
frequently than PTB (p < 0.001) (Table 1).
Among cases of EPTB, the proportion of white indi-
viduals and of individuals with more than seven years
of education was significantly greater (p < 0.001 for




















Figure 1 Clinical sites of extrapulmonary tuberculosis in Brazil, 2007 to 2011.
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(p < 0.001) and mental illness (p < 0.001) occurred more
frequently among patients with PTB, whereas the pro-
portion of patients co-infected with HIV (p < 0.001) and
having other co-morbidities diseases (p = 0.001) was greater
among patients with EPTB (Table 2).
Table 2 demonstrates that the proportions of new cases,
readmission cases following dropout, relapse cases, un-
known admission type cases, and transfer cases were
greater for EPTB than PTB. Although the percentages
of positive and negative TST were similar between
EPTB and PTB, the difference was statistically significant
(p < 0.001; Table 2). PTB patients were less frequently sub-
jected to tissue biopsy and histopathological examination
for diagnosis (p < 0.001), but were more often treated
under DOTS (p < 0.001). The number of deaths due to
pulmonary forms of TB was greater than the number of
deaths due to EPTB, and the number of deaths due to
other causes was higher for EPTB (p < 0.001; Table 2).
Due to the significance found with the chi-squared test
(Tables 1 and 2), all of the investigated variables were
included in the hierarchical model and remained signifi-
cant during the various stages of analysis as demonstrated
in Tables 3 and 4.
Males and institutionalized patients were less likely to
have EPTB (OR 0.77; 95% CI 0.76 – 0.78) and (OR 0.61;
95% CI 0.59 – 0.64), respectively (Table 3).
EPTB patients were more likely to be white, less
than fourteen years old (OR 2.52; 95% CI 2.39 – 2.65),
have more than 12 years of education (OR 4.93; 95% CI
4.61 – 5.28), and be HIV seropositive (OR 2.15; 95% CI
2.09 – 2.21) (Table 3).
Table 4 describes 3 levels of the hierarchical logistic
regression model. Level 2 which corresponds to comor-
bidities show that alcoholism (OR 0.46; 95% CI 0.43 –
0.46), mental illness (OR 0.88; 95% CI 0.82 – 0.95), and
diabetes mellitus (OR 0.54; 95% CI 0.51 – 0.57) occurred
less frequently in patients with EPTB compared to those
with PTB. The variables corresponding to level 4 associ-
ated with EPTB included admission due to transfer (OR
1.31; 95% CI 1.24 – 1.37), positive TST (OR 1.08; 95%
Table 1 Sociodemographic characteristics of EPTB and PTB in Brazil, 2007 – 2011
Characteristics N* Categories EPTB (%) (n = 53,853) PTB (%) (n = 356,341) P value**
Gender Female 22,472 (39.3) 115,541 (32.4) <0.001
(413,533) Male 34,743 (60.7) 240,777 (67.6)
Age 0-14 years old 3,743 (6.4) 10,733 (3.0) <0.001
(409,981) 15– 24 years old 7,543(14.0) 60,798 (17.1)
25– 34 years old 13,219 (24.6) 85,045(23.9)
35 – 44 years old 11,349 (21.2) 70,565 (19.8)
45 – 54 years old 8,616 (16.0) 61,198 (17.2)
55 – 64 years old 5,040 (9.4) 36,748 (10.3)
>65 years old 4,545 (8.4) 31,064 (8.7)
Skin color/race White 22,474 (45.2) 112,112 (36.0) <0.001
(361,362) Black 6,333 (12.8) 47,566 (15.3)
Brown 19,791 (39.9) 144,380 (46.3)
Asian 557 (1.1) 3,531 (1.1)
Indigenous 506 (1.0) 4,112 (1.3)
Education Illiterate 1,432 (4.1) 18,873 (8.4) <0.001
(258,978) 1 – 4 years 8,662 (24.6) 77,014 (34.4)
5 – 8 years 10,242 (29.1) 69,786 (31.2)
9 – 12 years 8,493 (24.2) 39,089 (17.5)
>12 years 4,490 (12.8) 11,818 (5.3)
Non-applicable 1,818 (5.2) 7,261 (3.2)
Dwelling Urban 37,948 (91.3) 241,956 (88.2) <0.001
(315,989) Rural 3,311 (8.0) 30,260 (11.0)
Peri-urban 273 (0.7) 2,241 (0.8)
Institutionalization No 45,605 (93.3) 270,977 (88.8) <0.001
(354,189) Yes 3,249 (6.7) 34,358 (11.2)
*Number of valid observations. **Pearson’s chi-squared test.
EPTB: Extrapulmonary tuberculosis. PTB: pulmonary tuberculosis.
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CI 1.02 – 1.13), and positive histopathological examin-
ation (OR 3.57; 95% CI 3.24 – 3.92). The variables in
level 4 that exhibited the least association with EPTB
were positive AFB smear test result (OR 0.12; 95% CI
0.12 – 0.13) and culture performed (OR 0.64; 95% CI
0.60 – 0.37).
Regarding the outcome variables, treatment was ad-
ministered under DOT less frequently in patients with
EPTB than PTB (OR 0.69; 95% CI 0.67 – 0.71), and
patients with EPTB were less likely to default during treat-
ment than patients with PTB (OR 0.79; 95% CI 0.76 –
0.83) (Table 4).
Discussion
In Brazil, although EPTB primarily affects adults, one-
fourth of all cases of EPTB occurred in children less
than 14 years of age. The age variable was not normally
distributed in our dataset. Thus, we built different
models including this variable as continuous and categor-
ical. The model with the better fit was with categorical
variable (Akaike Information Criterion (AIC) = 312853 to
continuous and AIC = 310940 to categorical). Also, the
choice of categories took into account those described
in the “Revised international definitions in tuberculosis
control” [20]. Other affected groups include whites,
Table 2 Comorbidities, clinical features, and treatment outcomes of EPTB and PTB in Brazil, 2007- 2011
Characteristics N* Categories EPTB (%) (n = 53,853) PTB (%) (n = 356,341) P value**
HIV/AIDS Negative 24,072 (69.2) 149,526 (83.8) <0.001
(213,336) Positive 10,755 (30.8) 28,983 (16.2)
Alcoholism No 46,056(91.6) 249,995 (82.0) <0.001
(355,292) Yes 4,236 (8.4) 55,005 (18.0)
Diabetes No 48,121 (96.1) 279,415 (92.9) <0.001
(350,756) Yes 1,960 (3.9) 21,260 (7.1)
Mental illness No 49,114 (98.1) 293,039 (97.3) <0.001
(351,236) Yes 960 (1.9) 8,123 (2.7)
Other diseases No 38,142 (83.8) 229,706 (84.7) 0.001
(316,784) Yes 7,357 (16.2) 41,579 (15.3)
Admission type New cases 50,126 (87.6) 290,431 (81.5) <0.001
(413,559) Relapse 2,178 (3.8) 23,013 (6.5)
Readmission after dropout 1,386(2.4) 23,191 (6.5)
Unknown 151 (0.3) 1,026 (0.3)
Transfer 3,376 (5.9) 18,681 (5.2)
TST Negative 4,745 (29.3) 14,461 (28.0) <0.001
(67,942) Positive 11,481 (70.7.2) 37,255 (72.0)
AFB smear Negative 23,936 (80.0) 82,602 (26.5) <0.001
(341,807) Positive 5,997 (20.0) 229,272 (73.5)
Culture Negative 6,775 (59.3) 22,103 (33.2) <0.001
(78,004) Positive 4,648 (40.7) 44,478 (66.8)
Histopathology Negative 884 (3.8) 2,184 (9.9) <0.001
(44,855) Positive 21,903(96.2) 19.884 (90.1)
DOT Not performed 28,727 (64.7) 153.811 (51.7) <0.001
(341,831) Performed 15,696 (35.3) 143,597 (48.3)
Outcome status Cure 30,186(71.5) 186,428 (70.1) <0.001
(308,112) Dropout 3,429 (8.1) 33,016 (12.4)
Death by TB 1,564 (3.7) 10,718 (4.0)
Death by other causes 3,024 (7.2) 11,046 (4.2)
Transfer 3,967 (9.4) 23,566 (8.9)
MDR-TB 28 (0.1) 1,140 (0.4)
*Number of valid observations. **Pearson’s chi-squared test.
HIV/AIDS: human immunodeficiency virus/acquired immunodeficiency syndrome. TST: tuberculin skin test. AFB: acid-fast bacilli. DOT: Directly Observed Therapy.
EPTB: Extrapulmonary tuberculosis. PTB: pulmonary tuberculosis.
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individuals with 5 to 8 years of formal education, resi-
dents of urban areas, and non-institutionalized individ-
uals. Histopathological examination of affected sites and
tissues is usually recommended for diagnosis, and a large
number of samples from patients with EPTB are AFB
positive. The low proportion of patients with extrapul-
monary TB treated under DOT should alert the national
TB control program to the possible underuse of DOT in
patients with EPTB and potentially lower cure rates in
such patients. The high rate of transfers suggests the
difficulties or lack of knowledge associated with the
management of patients with EPTB.
Limitations of our study include deficiencies in the
secondary databases including, possible missing or incom-
plete data, and potential biases and errors during data
entry. We analyzed data for patients with pulmonary and
extrapulmonary forms of TB. Additional studies of pa-
tients with combined pulmonary and extrapulmonary
TB are needed to understand the characteristics of such
patients.
Nevertheless, because the number of TB cases in our
study was large and national TB surveillance data in
Brazil are reasonably complete, our statistical analysis is
robust and remains significant. In addition, it is believed
that EPTB might be underreported due to its difficult
diagnosis, which requires a high degree of clinical suspi-
cion and biopsy or culture for confirmation. Strengths of
our study include its national scope, the use of a hierarch-
ical logistic regression model, and its new contribution to
the knowledge about EPTB in Brazil.
We found that the most frequent site of EPTB was the
pleura, followed by the peripheral lymph nodes. In the US
between 1993 and 2006, the lymph node was the most
common site of extrapulmonary involvement, followed by
the pleura [16]. Tuberculous pleurisy occurs frequently in
association with PTB. Moreover, evidence suggests that
pleural TB represents an early manifestation of primary
infection by Mycobacterium tuberculosis (MTB) and
may serve as a sentinel event in recent transmission
studies [21].
The proportion of cases of EPTB relative to the other
clinical forms of TB exhibits wide variation among dif-
ferent countries and seems to be higher in those with a
low incidence of TB, such as the US (21%), Italy (32%),
Japan (23%) and Australia (39%) [1]. The reasons for
these differences are unknown but could be related to
different epidemiological patterns and the proportions
of persons with TB as a consequence of recent (as op-
posed to remote) infection [21]. It is believed that in
these in developed countries the proportion of patients
with PTB, primarily responsible for the transmission of
TB to other persons is lower, under such conditions
EPTB has become more perceptive in actual epidemio-
logical studies. Also the subnotifications of EPTB due
the intrinsic difficulties in EPTB diagnosis and the lack
of access to adequate diagnostic infrastructure in high
TB burden developing countries could have also con-
tributed to the observed EPTB disparity between the TB
high burden developing countries and low incidence
developed countries.
Conversely, in countries with a high incidence of TB,
EPTB usually represents a smaller fraction of all cases.
In 2011, the proportion of EPTB was 19% in India, 4%
in Indonesia, and 18% in Pakistan. Our study demonstrated
that the proportion of EPTB was 12.6% which is similar
to high TB burden countries [1,9].
The higher proportion of females in EPTB cases com-
pared with PTB cases was statistically significant, confirm-
ing other studies [16,22-24]. The association between
white race and EBTB found in the present study disagrees
with the results found in a US study where 81% of cases of
EPTB occurred among non-whites [16]. Investigators in
Table 3 Hierarchical logistic regression of forms of TB
and sociodemographic characteristics, Brazil, 2007 – 2011
Level Characteristics OR * CI (95%) **
Level 1 Gender Female Reference
Male 0.77 0.76 – 0.78
Age 0 – 14 years old 2.52 2.39 – 2.65
15 – 24 years old 0.76 0.74 – 0.78
25 – 34 years old Reference
35 – 44 years old 1.11 1.08 – 1.14
45 – 54 years old 0.99 0.96 – 1.02
55 – 64 years old 1.00 0.96 – 1.03
>60 years old 1.13 1.09 – 1.17
Skin color/race White Reference
Black 0.75 0.72 – 0.77
Brown 0.75 0.73 – 0.77
Asian 0.82 0.75 – 0.90
Indigenous 0.63 0.57 – 0.70
Education Illiterate Reference
1 – 4 years 1.49 1.39 – 1.58
5 – 8 years 2.00 1.88 – 2.13
9 – 12 years 3.09 2.90 – 3.29
>12 years 4.93 4.61 – 5.28
Non-applicable 2.19 2.07 – 2.33
Level 2 Dwelling Urban Reference
Rural 0.82 0.79 – 0.85
Peri-urban 0.89 0.78 – 1.01
Institutionalization No Reference
Yes 0.61 0.59 – 0.64
*OR: Odds Ratio of EPTB outcomes compared to PTB **CI: confidence interval.
HIV/AIDS: human immunodeficiency virus/acquired immunodeficiency
syndrome. EPTB: extrapulmonary tuberculosis. PTB: pulmonary tuberculosis.
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the UK and Germany have reported that EPTB is more
prevalent among particular racial groups, such as
Asians, whereas it is less frequent among Caucasians
[10,23]. In another Brazilian study of 606 patients with
TB an association between EPTB and white race was
also present [25]. The predominance of the white race
also differs between the cases of PTB in Brazil, where
individuals of brown and black ethnicity are most af-
fected by PTB [10].
Our analysis also demonstrated that a higher educa-
tion level was associated with a higher frequency of
EPTB. In Brazil this result may be related to easier
access to diagnostic and health services among more
educated individuals, given that the diagnosis of EPTB
often requires invasive sampling procedures with
additional expense and risk, and the collection of such
samples is more difficult in public health services of
resource-constrained countries [26]. We were unable to
identify other international studies examining educational
level and extrapulmonary TB to compare our findings.
Regarding clinical factors, our analysis confirms many
earlier reports [4,6,10,16,27] of the strong association
between HIV co-infection and extrapulmonary TB. In a
Brazilian study on TB-HIV coinfection between 2006 and
2010, EPTB occurred in 26.2% of HIV-infected patients
[28]. In a recent meta-analysis, the pooled analysis showed
a significant relationship between HIV infection and EPTB
(OR:1.3, CI 1.05-1.6) [29].
The fact that 39.9% of the cases of EPTB were awaiting
HIV test results or were not tested deserves particular at-
tention. A smaller number of patients with TB who are
tested for HIV correlates with a greater uncertainty rela-
tive to the prevalence of coinfection [30]. All patients who
give consent must be tested for HIV, and mechanisms
should be established to ensure that the results are sys-
tematically included in information systems as soon as
they become available [30].
The most frequent type of admission of patients with
EPTB to the health system was through transfers. This
phenomenon may be related to the greater difficulty of
health professionals in peripheral health units to confi-
dently diagnose EPTB; thus, it is necessary to refer pa-
tients to other services for diagnostic confirmation or
to begin treatment without confirmation based on a
high degree of clinical suspicion and negative AFB
smear results [31].
Mycobacterial cultures are not universally performed
during evaluation of TB suspects in Brazil and are indi-
cated only in specific instances, such as in cases of sus-
pected EPTB or drug resistant TB and in vulnerable
populations [32]. For this reason, cultures were performed
in a larger proportion of cases of EPTB compared with
PTB in our study, although cultures were positive in a
smaller fraction of EPTB patients.
Anti-TB treatment was not conducted under DOT in
64.7% of the cases of EPTB, which is significantly higher
compared with PTB cases. Among the recommendations
for the treatment of EPTB, lack of adherence, poor
absorption of anti-TB drugs, and drug resistance must
be considered as possible reasons for the delayed or sub-
optimal response to appropriate treatment, and DOT is
strongly recommended to enhance treatment completion
and cure of the patient [33].
Table 4 Hierarchical logistic regression of forms of TB
and clinical characteristics, Brazil, 2007 – 2011
Level Characteristics OR * CI (95%) **
Level 3 HIV/AIDS Negative Reference
Positive 2.15 2.09 – 2.21
Alcoholism No Reference
Yes 0.45 0.43 – 0.46
Diabetes No Reference
Yes 0.54 0.51 – 0.57
Mental illness No Reference
Yes 0.88 0.82 – 0.95
Other diseases No Reference
Yes 1.18 1.15 – 1.22
Level 4 Admission type New cases Reference
Relapse 0.65 0.62 – 0.69
Readmission after
dropout
0.39 0.37 – 0.42
Unknown 0.66 0.53 – 0.81
Transfer 1.31 1.24 – 1.37
TST Negative Reference
Positive 1.08 1.02 – 1.13
AFB smear Negative Reference
Positive 0.12 0.12 – 0.13
Culture Negative Reference
Positive 0.64 0.60 – 0.67
Histopathology Negative Reference
Positive 3.57 3.24 – 3.92
Level 5 DOT Not performed Reference
Performed 0.69 0.67 – 0.71
Exit condition Cure Reference
Dropout 0.79 0.76 – 0.83
Death by TB 0.73 0.68 – 0.79
Death by other
causes
1.05 1.00 – 1.12
Transferal 1.24 1.18 – 1.30
MDR-TB 0.43 0.27 – 0.68
*OR: Odds Ratio of EPTB outcomes compared to PTB **CI: confidence interval
TST: tuberculin skin test. AFB: acid-fast bacilli. DOT: Directly Observed Therapy.
EPTB: extrapulmonary tuberculosis. PTB: pulmonary tuberculosis.
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EPTB is an important health problem due to its high
mortality and morbidity rates, both in developing and
developed countries [34]. EPTB is less contagious, less
frequent than PTB, and less well addressed by programs in
developing countries, but improved diagnosis of extrapul-
monary forms of TB and supervised treatment are essen-
tial prerequisites for optimizing care and better treatment
outcomes [35].
Knowledge about determinants and characteristics of
patients with EPTB from our study should motivate
more investigation of extrapulmonary involvement to
improve patient care and TB control in Brazil.
Conclusions
As can be seen in our study, characteristics of EPTB
often differ from those of PTB, as well as from those re-
ported in countries with a low burden of TB. Therefore,
studies aiming at these differences are important.
Beyond identification of EPTB cases, special diagnostic
methods like aspirates and biopsies must be guaranteed
but the resources to do them are limited in many parts
of Brazil. Improved diagnostic capacity is essential for
better case finding and management of EPTB. Because
EPTB is less infectious to others in the community, it
may receive less attention than smear-positive PTB from
TB programs and health units with limited resources.
More specific programs and resources are needed to
improve the diagnosis, treatment and outcome of EPTB
in Brazil.
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